The investigators are evaluating the role of a low dose of tocilizumab in treating acute chest syndrome in patients with sickle cell disease. Tocilizumab inhib…

Sickle Cell DiseaseAcute Chest Syndrome

~Estimated

~$10 – $6,250

University of ChicagoNCT05640271

Observational

Use of Point-of-Care Ultrasound (POCUS) for the Diagnosis of Acute Chest Syndrome in Patients With Sickle Cell Disease

Feasibility and reliability of ultrasound in the inpatient hematology setting.

Acute Chest SyndromeSickle Cell Disease

~Estimated

~$10 – $6,250

Indiana UniversityNCT06880679